Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease-Reference-Cited by-同舟云学术

Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease

Published:2015-03 Issue:10 Volume:33 Page:1274-1283
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Bontempi Iván Alejandro,Vicco Miguel Hernán,Cabrera Gabriel,Villar Silvina Raquel,González Florencia Belén,Roggero Eduardo Angel,Ameloot Paul,Callewaert Nico,Pérez Ana Rosa,Marcipar Iván Sergio

Funder

ANPCyT

CONICET

Universidad Nacional del Litoral, Argentina

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference54 articles.

1. Treatment of chronic Chagas’ disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up;Viotti;Am Heart J,1994

2. Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice;Dumonteil;Infect Immun,2004

3. Identification of novel vaccine candidates for Chagas’ disease by immunization with sequential fractions of a trypomastigote cDNA expression library;Tekiel;Vaccine,2009

4. TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice;Gupta;PLOS ONE,2013

5. Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection;Miyahira;Infect Immun,2005

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trypanosoma cruzi infection: strategies for the development of a vaccine;SCT Proceedings in Interdisciplinary Insights and Innovations;2024-06-12

2. Protective Efficacy of the Epitope-Conjugated Antigen N-Tc52/TSkb20 in Mitigating Trypanosoma cruzi Infection through CD8+ T-Cells and IFNγ Responses;Vaccines;2024-06-04

3. Vaccination with parasite-specific TcTASV proteins combined with recombinant baculovirus as a delivery platform protects against acute and chronic Trypanosoma cruzi infection;Frontiers in Cellular and Infection Microbiology;2024-02-28

4. The high identity of the Trypanosoma cruziGroup‐I of trans‐sialidases points them as promising vaccine immunogens;Proteins: Structure, Function, and Bioinformatics;2023-06-16

5. Intranasal trans-sialidase-based vaccine against Trypanosoma cruzi triggers a mixed cytokine profile in the nasopharynx-associated lymphoid tissue and confers local and systemic immunogenicity;Acta Tropica;2023-05